XTL Biopharma (XTLB) Reports Q2 Loss of $0.002/Share
Tweet
Share
E-mailGet Alerts XTLB Hot Sheet
Join SI Premium – FREE
XTL Biopharma (NASDAQ: XTLB) reported Q2 EPS of $-0.002, versus $-0.001 reported last year.
For earnings history and earnings-related data on XTL Biopharma (XTLB) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- Zeo Energy Corp (ZEO) Misses Q2 EPS by 7c
- Neumora Therapeutics, Inc. (NMRA) Tops Q2 EPS by 4c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
